skip to content

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.